Kevin Tan
Chief Financial Officer
Replay available
Selecta Biosciences, Inc. (SELB) Q3 2021 Earnings Call
Selecta Biosciences, Inc. (NASDAQ: SELB) Q3 2021 earnings conference call, held 2021-11-09. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Carson Bruhn
President and Chief Executive Officer
Peter Traber
Chief Medical Officer
Kay Kishimoto
Chief Scientific Officer
Kristin Kluska
Analyst, Cantor Fitzgerald
Raju Prasad
Analyst, William Blair
Gil Bloom
Analyst, Needham & Company
Xun Zhang
Analyst, BTIG
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Cartesian Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.009 -- 00:00:05.232 Good morning, and welcome to the Selecta Biosciences third quarter 2021 financial results 00:00:05.232 -- 00:00:09.895 and corporate update conference call. Currently, all participants are in a listen-only 00:00:09.895 -- 00:00:14.898 mode. This call is being webcast live on investors and media section of 00:00:14.898 -- 00:00:18.779 Selecta's website at www.selectabio.com, 00:00:19.801 -- 00:00:23.243 and it is being recorded. For 00:00:23.243 -- 00:00:27.926 opening remarks, I would like to introduce Kevin Tan, Chief Financial Officer of Selecta. 00:00:27.926 -- 00:00:29.261 Please go ahead. 00:00:29.261 -- 00:00:33.802 Thank you and good morning. Welcome to our third quarter 2021 financial 00:00:33.802 -- 00:00:37.523 results and corporate update conference call. 00:00:37.523 -- 00:00:41.765 The press release reporting our financial results is available in the investors and media 00:00:41.765 -- 00:00:46.185 section of Selective's website, www.selectivebio.com. 00:00:47.706 -- 00:00:52.648 And the quarterly report on Form 10Q ended September 30th, 2021, 00:00:52.648 -- 00:00:58.329 which was filed today with the Securities and Exchange Commission, or SEC. 00:00:58.576 -- 00:01:03.719 Joining me today are Carson Bruhn, President and Chief Executive Officer, Peter 00:01:03.719 -- 00:01:09.343 Traber, Chief Medical Officer, and Kay Kishimoto, Chief Scientific 00:01:09.343 -- 00:01:10.904 Officer. 00:01:10.904 -- 00:01:15.546 During today's call, we will be making certain forward-looking statements, including 00:01:15.546 -- 00:01:17.327 without limitation, 00:01:17.327 -- 00:01:22.531 statements about the potential safety, efficacy, and regulatory 00:01:22.531 -- 00:01:27.793 and clinical progress of our product candidates, financi...